Alterity Therapeutics Limited
ATH
株式のランク
#25473
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
株価
$0.21511186
最終同期: 2026-10-16
時価総額
$47.00M
変化（1日）
0.00%
変化（1年）
-38.54%
国
AU
取引 Alterity Therapeutics Limited (ATH)
カテゴリー
Healthcare
の時価総額 Alterity Therapeutics Limited(ATH)
時価総額: $47.00M
October 2026時点で、Alterity Therapeutics Limited の時価総額は $47.00M です。これは、当社のデータによると、Alterity Therapeutics Limited が世界で25473rd番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Alterity Therapeutics Limited の時価総額の履歴（2012 から 2026 まで）
